Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is clear cell sarcoma?
Clear cell sarcoma is a rare soft-tissue sarcoma that most often affects adolescents and younger adults. A sarcoma is a cancer of the body's connective tissues; clear cell sarcoma typically arises deep in the soft tissues near tendons and the tough sheets of tissue called aponeuroses, most commonly in the foot, ankle, or lower leg, and less often in the hands, arms, or trunk. It usually appears as a slowly growing, firm, often painful mass attached to a tendon, and because it grows gradually it may be present for months to years before diagnosis. One of the most distinctive things about clear cell sarcoma is that its cells make melanin, the same pigment found in skin cancer (melanoma), and under the microscope it can closely resemble melanoma — which is why it was once called 'melanoma of soft parts.' Despite that resemblance, it is a true sarcoma, not a skin melanoma, and it is defined at the molecular level by a characteristic gene fusion (an EWSR1 rearrangement) that melanoma does not have; finding that fusion confirms the diagnosis and distinguishes the two. This distinction matters because the two cancers behave and are treated differently. Like a few other sarcomas — and like melanoma — clear cell sarcoma can spread to nearby lymph nodes as well as to the lungs, so the regional nodes are evaluated. The cornerstone of treatment is complete surgical removal with wide margins. Radiation is commonly combined with surgery to treat the microscopic disease that extends beyond the visible tumor and to lower the chance of local recurrence, particularly in the small, functionally important structures of the foot and ankle. Because clear cell sarcoma generally does not respond well to standard chemotherapy, controlling it locally with surgery and radiation, and watching closely for spread, is especially important; clinical trials of targeted and immune therapies are an active area for advanced disease.
The main types
Doctors group clear cell sarcoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Extremity (foot / ankle) clear cell sarcoma | The typical presentation — a firm, often painful mass attached to a tendon in the foot, ankle, or lower leg; treated with wide surgery and often radiation to preserve function in these delicate areas. |
| Clear cell sarcoma of other soft-tissue sites | Less commonly arises in the hand, arm, trunk, or elsewhere; treated with the same combination of wide surgery and radiation, individualized to the location. |
| Node-involving clear cell sarcoma | Because this tumor can spread to nearby lymph nodes (like melanoma and unlike most sarcomas), the regional nodes are evaluated and addressed with surgery and/or radiation if involved. |
| Gastrointestinal clear cell sarcoma-like tumor | A rare related tumor arising in the digestive tract rather than the limbs; recognized as a distinct, aggressive entity and managed by a sarcoma team. |
Staging, in plain terms
Clear cell sarcoma is staged with the soft-tissue sarcoma TNM system, but like epithelioid sarcoma it has a feature uncommon among sarcomas: it can spread to nearby lymph nodes, so the N category and examination of the regional nodes matter more here than for the typical soft-tissue sarcoma. The T category reflects the size and depth of the tumor, the M category notes distant spread (most often to the lungs, and also to lymph nodes), and the grade describes how aggressive the cells look. The diagnosis is confirmed not by stage but by molecular testing. Under the microscope, clear cell sarcoma makes melanin and looks strikingly like melanoma, but it carries a characteristic EWSR1 gene fusion that melanoma lacks; finding that fusion proves it is a sarcoma and not a skin cancer, which changes how it is treated. Beyond the formal stage, two behaviors shape care: the tumor's attachment to tendons and tissue planes, which means surgery and radiation must cover more than the visible mass, and its ability to reach lymph nodes, which means the nodes must be evaluated. In practice, the key questions are the size and location of the tumor (especially in the small structures of the foot and ankle), whether the regional lymph nodes are involved, and whether it has spread to the lungs. Because standard chemotherapy works poorly against this tumor, the staging emphasis on local control and on lymph nodes directly drives the surgery-and-radiation plan.
| Soft-tissue sarcoma TNM with grade — tumor size and depth (T), lymph nodes (N), distant spread (M), and grade; an EWSR1 gene fusion confirms the diagnosis and distinguishes it from melanoma | What it generally means |
|---|---|
| Localized, small | A tumor confined to its site, often attached to a tendon; treated with wide surgery and often radiation, with evaluation of the nearby lymph nodes. |
| Localized, larger or deep | A bigger or deeper tumor still confined locally; treated with wide surgery and radiation to control microscopic disease and preserve function. |
| Regional (lymph node) spread | Cancer that has reached nearby lymph nodes — uncommon for sarcomas but seen here, like melanoma; treated with surgery to the nodes and/or radiation, in addition to the primary tumor. |
| Metastatic (lungs or beyond) | Cancer that has spread to distant sites such as the lungs; treated within clinical trials of targeted/immune therapy when possible, with radiation for symptom control or limited deposits. |
The standard of care
Clear Cell Sarcoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Wide surgical removal
Removing the tumor with generous margins is the central treatment; because clear cell sarcoma attaches to tendons and tissue planes, the operation aims to capture microscopic disease beyond the visible mass while preserving function.
Radiation therapy (with surgery)
Commonly combined with surgery to treat the microscopic disease that extends along tendons and tissue planes; it lowers the chance of local recurrence and helps preserve the foot, ankle, or limb.
Lymph-node evaluation
Because this tumor can spread to nearby lymph nodes (like melanoma), the regional nodes are examined and imaged, and addressed with surgery and/or radiation if involved — a step that matters more here than for most sarcomas.
Molecular diagnosis
Testing for the EWSR1 gene fusion confirms clear cell sarcoma and distinguishes it from melanoma, which looks similar but is treated differently — a crucial step for correct treatment.
Sarcoma specialty center care and trials
Because standard chemotherapy works poorly, treatment at a sarcoma center — with strong local control and access to clinical trials of targeted and immune therapies for advanced disease — offers the best path.
How radiation treatment works
Radiation therapy treats clear cell sarcoma by delivering focused beams of energy that damage the DNA inside tumor cells so they can no longer grow and divide. Radiation is an important partner to surgery here for two reasons. First, like other soft-tissue sarcomas, clear cell sarcoma extends microscopically beyond its visible mass — and it characteristically attaches to and creeps along tendons and the tough tissue planes of the foot, ankle, and limb. Removing only the visible tumor risks leaving those microscopic extensions behind to seed a recurrence, so radiation treats a wider zone, following the tissue planes, to sterilize that disease. Second, clear cell sarcoma so often occurs in the small, functionally critical, weight-bearing structures of the foot and ankle in a young person, where removing a very wide margin of tissue would be disabling; pairing a more conservative operation with radiation makes it possible to control the cancer while preserving the limb and its function. Radiation can be given before or after surgery: beforehand it uses a smaller field and a lower dose and can make a function-preserving operation more achievable, though it requires extra attention to wound healing; afterward it treats the tumor bed at a higher dose over a larger area. Modern techniques such as intensity-modulated radiation shape the dose tightly around the target to spare the surrounding tendons, bone, and delicate structures. Clear cell sarcoma is also one of the few sarcomas that — like the melanoma it resembles — can spread to nearby lymph nodes, so radiation may be directed at the regional nodes when they are involved or at risk. Because this tumor responds poorly to standard chemotherapy, strong local control with surgery and radiation, plus close surveillance of the lymph nodes and lungs, carries even more weight than it does for many other sarcomas; for advanced disease, radiation controls symptoms and limited deposits while clinical trials explore targeted and immune therapies.
The main ways radiation is delivered for clear cell sarcoma:
Preoperative (neoadjuvant) radiation
Radiation given before surgery treats microscopic disease along tendons and tissue planes using a smaller field and lower dose, which can make a function-preserving operation in the foot or ankle more achievable, at the cost of more wound-healing care.
Postoperative (adjuvant) radiation
Radiation to the tumor bed after surgery, used when preoperative radiation wasn't given, sterilizes microscopic disease left behind and lowers the chance of local recurrence, at a higher dose over a larger area.
Intensity-modulated radiation (IMRT)
Shaping the beams tightly around the target spares the surrounding tendons, bone, and small structures of the foot and ankle, helping preserve function in these delicate, weight-bearing locations.
Radiation to lymph nodes
When nearby lymph nodes are involved or at risk — a possibility this tumor shares with melanoma — radiation can treat the nodal area along with, or instead of, surgery to the nodes.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
EWSR1 gene fusion distinguishes clear cell sarcoma from melanoma: Molecular studies confirm that clear cell sarcoma carries a characteristic EWSR1 gene fusion absent in melanoma, providing a reliable way to tell apart these look-alike cancers and ensure each is treated correctly.[1]
Clear cell sarcoma molecular diagnostic studies
Surgery plus radiation for local control: Because clear cell sarcoma attaches to tendons and recurs locally, series support combining wide surgery with radiation to treat microscopic disease and preserve function, especially in the foot and ankle.[2]
Clear cell sarcoma local-control studies
Limited benefit of standard chemotherapy drives trial enrollment: Studies show clear cell sarcoma responds poorly to conventional chemotherapy, underscoring the importance of strong local treatment and motivating clinical trials of targeted (e.g. MET-pathway) and immune therapies for advanced disease.[3]
Clear cell sarcoma systemic therapy and trial reports
Common questions
Is clear cell sarcoma the same as melanoma? No, though they look remarkably alike. Clear cell sarcoma makes melanin — the same pigment as melanoma — and under the microscope the two can be nearly indistinguishable, which is why clear cell sarcoma was once called 'melanoma of soft parts.' But it is a true soft-tissue sarcoma, not a skin cancer, and it carries a characteristic EWSR1 gene fusion that melanoma does not have. Finding that fusion is how the diagnosis is confirmed. The distinction matters because the two cancers are treated differently — getting it right ensures you receive the correct surgery, radiation, and, for advanced disease, the appropriate drug therapy or clinical trial.
Why does the team check my lymph nodes? Most soft-tissue sarcomas rarely spread to lymph nodes, but clear cell sarcoma is one of the exceptions — like the melanoma it resembles, it can travel to the nodes near the tumor. Because of this, the team examines and images the regional lymph nodes as part of staging, and if any are involved they are treated with surgery and/or radiation along with the primary tumor. Watching the nodes is an important part of comprehensive care for this particular sarcoma.
Why is local treatment so emphasized for this cancer? Clear cell sarcoma generally does not respond well to standard chemotherapy, so the most effective tools for controlling it are surgery and radiation directed at the tumor and, when needed, the lymph nodes. That makes a complete, well-planned local treatment — wide surgery combined with radiation to cover the microscopic disease along tendons and tissue planes — especially important, along with close follow-up to catch any spread early. For advanced disease, clinical trials of targeted and immune therapies are an active area, and a sarcoma center can help you access them.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.